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I. Abstract Page 
Within biological milieu, proteins adsorb onto the surface of nanoparticles to form a corona 
to drive the behaviour of nanomaterials in vivo. In a previous report, Smith et al. (2012) 
showed that the presence of serum inhibited interactions between carboxylate modified 
20nm polystyrene nanoparticles and two cell lines (HeLa and MDCK), and caused a 
reduction in the surface charge of these nanoparticles. In this study the effects of different 
concentrations of serum and Bovine Serum Albumin (BSA) on the interactions between 
spherical carboxylated polystyrene particles and the plasma membrane are investigated. 
Similarly, the effects of varying concentrations of serum on the surface charge of these 
particles were also studied. 20nm, 200nm, and 1µm polystyrene particles were investigated, 
and it was found that the inhibitory effect of serum on nanoparticle-plasma membrane 
interactions was dependent on particle size and serum concentration. BSA was not found to 
induce the same level of inhibition at equivalent concentrations. The reduction in surface 
charge was shown to plateau at relatively low concentrations of serum (approximately 1%), 
suggesting that while the total amount of protein bound to these particles remained constant 
beyond this point, the composition of the corona would continue to change as serum 
concentration increased, thus causing increasing inhibition of particle-membrane 
interactions.  
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SECTION 1:  INTRODUCTION 
Defined as materials with at least one dimension below 100nm, nanoparticles (NPs) exhibit 
a number of unique properties and behaviours that are proving invaluable in diverse 
medical and commercial roles (Zhang et al. 2011; McCall 2011; Weir et al. 2012). In this 
introductory section, the diverse applications of various nanomaterials are illustrated, as 
well as vehicular and industrial sources of particulate matter in the environment (Weir et al. 
2012; Nohynek and Dufour 2012). The current concerns about the potentially harmful 
effects of nanoparticle exposure and usage will then be discussed in the context of the 
increasing exposure to nanoparticles as a consequence of their increasingly widespread use 
(Li et al. 2011; Libutti et al. 2010).  
The behaviour of nanoparticles in physiological conditions will be explored, with a 
particular focus on the formation of a protein corona in biological media (Nel et al. 2009). 
Finally, previous work into the effects of the corona on nanoparticle interactions with cells 
will be presented as an introduction to the study reported here (Smith et al. 2012).  
1.1 Commercial and Medical Applications of Nanoparticles 
Silver and gold nanoparticles are classic examples of nanoparticles with broad commercial 
and medicinal applications (Dankovich and Gray 2011;Ghosh et al. 2008). Silver 
nanomaterials possess potent anti-microbial properties, and these have been exploited in a 
range of commercial fabrics and medical dressing materials (Maneerung et al. 2008; Zhang 
et al. 2009; Lorenz et al 2012). The anti-microbial properties of silver nanoparticles have 
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also been integrated into water filtration systems, both on their own and as part of 
nanocomposites, to provide a potentially effective, reliable, and cheap method of water 
purification which remains sorely needed in many parts of the world (Seo et al. 2012; Hillie 
and Hlophe 2007; Dankovich and Gray 2011). 
Gold nanoparticles have proven effective in the field of cancer treatment, with applications 
in drug delivery and imaging (Llevot and Astruc 2012). The unique optical properties of 
gold nanoparticles allow for a novel method of imaging neoplasms through photoacoustic 
imaging, a technology which combines the high resolution offered by ultrasonic and the 
absorption contrast provided by optical imaging to offer a safe and effective method of 
imaging a wide range of pathologies (Li et al 2011).  
As drug delivery vectors gold nanoparticles are rapidly emerging as effective and safe 
methods of delivering otherwise toxic therapies to malignancies (Figure 1) (Llevot and 
Astruc 2012). Aurimmune (CYT-6051), a therapy composed of 27nm gold nanoparticles 
functionalised with recombinant tumour necrosis factor alpha (rTNF-alpha) has 
successfully passed phase I trials, effectively delivering rTNF-alpha to tumours in human 
patients without demonstrating the severe hepatotoxicity and other side effects caused by 
the drug when delivered by other means (Libutti et al. 2010). 
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A wide range of other materials have been used to generate nanoparticles with broad 
applications, including, carbon fullerenes and nanotubes which have found invaluable uses 
in fields as diverse as medicine, electrochemistry, and fuel cell technologies (Lota, Fic, and 
Frackowiak 2011; Yang et al 2012; Kosteralos, Bianco, and Prato 2009). Titanium oxide 
nanoparticles have found roles as important UV absorbers in skin products, photocatalysts, 
and next generation optical storage media (Yu, Ma, and Liu 2011; Ohkoshi et al 2010; 
Pinnell et al. 2000).  
A number of personal care products contain nanoparticles, an example of these are 
sunscreens which contain NPs like titanium dioxide and zinc oxide (Nohynek and Dufour 
2012). These nanoparticles are efficient absorbers of ultraviolet (UV) radiation and offer 
Figure 1 Image depicting the different 
therapeutic applications of gold 
nanoparticles (GNPs). These 
nanoparticles accumulate preferentially in 
tumours due to the Enhanced 
Permeability and Retention Effect (EPR), 
which is caused by the poor architecture 
and drainage typical of tumour 
vasculature. Because of EPR, gold 
nanoparticles passively target cancer cells 
and so are effective vectors for drug and 
gene therapies. Gold NPs can be further 
targeted by functionalization with tumour 
receptor specific ligands. GNPs can also 
be used for the thermal ablation of 
cancers, and these many uses of GNPs 
are being integrated into novel 
combinatorial approaches (Image from 
Ghosh et al. 2008). 
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significant benefits in terms of protecting skin cells from UV damage (Nohynek and 
Dufour 2012). Both zinc oxide and titanium dioxide are also used as additives in the food 
industry for their significant anti-microbial effects (Sharma, Anderson, and Dhawan 2012; 
Weir et al. 2012). 
Despite the diverse uses for which nanoparticles are being developed, there remain a 
number of unanswered questions about their behaviour in vivo, particularly in terms of their 
potentially harmful effects (McCall 2011).  
1.2 Concerns about Nanoparticle Safety 
According to manufacturer reports there are an estimated 1,300 commercial products 
containing nanoparticles (McCall 2011). However there is currently no legislation in force 
that requires manufacturers to report on the presence of nanoparticles in their products, and 
as such the true number of products is likely to be much higher (Weir et al. 2012). What 
this means is that there is a potential for significant exposure to a variety of different 
nanoparticles which have yet to be identified and characterised in terms of their toxicity 
(harmful effects detrimental to cell or organ function and survival) (Weir et al. 2012; 
McCall 2011). This issue becomes particularly important as more and more nanoparticles 
are making their way into commercial usage, and hence general exposure (Weir et al. 2012; 
Nohynek and Dufour 2012).  
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Recent research has provided evidence of the toxic potential of zinc oxide particles, 
showing that exposure to these nanoparticles can result in toxic accumulation of reactive 
oxygen species (ROS) in human liver, bronchial, epithelial, and epidermal keratinocyte cell 
lines (Lee et al. 2012; Heng et al. 2010; Sharma et al. 2009; Sharma, Anderson, and 
Dhawan 2012). The accumulation of ROS, a cellular condition known as oxidative stress, 
can disrupt a number of important cellular processes and, if left unchecked, can cause DNA 
damage and ultimately cell death (Kirt and Appel 2004). 
Oxidative stress has been observed as a consequence of exposure to titanium dioxide in 
human cell lines as well as in vivo systems like mice and Daphnia (Park et al 2008; 
Trouiller et al. 2009; Lovern and Klaper 2006). Titanium dioxide is a nanomaterial of 
Figure 2 In a study of a range of popular commercially available food products substantial 
concentrations of titanium nanoparticles were found. Titanium nanoparticles can be detected in a 
number of different food products, and hence understanding the consequences of exposure to these 
particles is critical (Image from Weir et al. 2012). 
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particular concern because of its widespread presence in commercial foods (Figures 2 and 
3) (Weir et al. 2012).  
However a criticism of these studies is that they do not effectively reproduce the conditions 
of exposure to these nanoparticles in the context of their use, and are not directly 
comparable to particles found in commercial products in terms of their physicochemical 
properties, surface functionalisation, and aggregation states (McCall 2011; Nohynek and 
Dufour 2012). As will be discussed in more detail in later Sections, these characteristics are 
critical to accurately evaluating the physiological effects of nanoparticles as they drive NP 
Figure 3 Graph depicting the concentration of titanium (present as titanium dioxide nanoparticles) 
found in a number of widely used commercial products.  The presence of these nanoparticles in 
such a diverse range of products once again illustrates the need for an understanding of any 
potentially toxic effects of exposure to titanium dioxide (Image from Weir et al. 2012). 
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interactions with biological materials, and hence toxicity and pharmacokinetics (Jiang et al. 
2008; Verma and Stellaci 2010; McCall 2011).  
Concerns about potential toxic exposure have also been raised about a number of other 
nanomaterials making their way into use, the most notable being gold nanoparticles (Ghosh 
et al. 2008). The in vivo toxicity, distribution, absorption, and clearance of gold 
nanoparticles have only recently been characterised, and studies have shown that the 
toxicity of these particles is very much dependent on shape, surface chemistry, size, dose, 
and route of administration (Zhang et al. 2012; Goodman et al. 2004; Pan et al. 2007).  
For example Zhang et al. (2010) have shown that orally and intraperitoneally administered 
13.5nm citrate coated gold nanoparticles caused significant toxicity in vivo (evidenced by a 
reduction in blood cell count, spleen index, and body weight), while NPs of the same size 
and physicochemical properties administered intravenously by the same authors caused no 
discernible toxic effects. Cho et al. (2009) however, found that gold nanoparticles of the 
same size but different surface chemistry (the authors used gold NPs coated with 
polyethylene glycol (PEG)) caused acute liver toxicity after intravenous administration. 
Similarly toxicity through liver damage has been demonstrated in polyethylene glycol 
(PEG) functionalised gold nanoparticles of 10nm and 60nm diameters, while 5nm and 
30nm particles did not demonstrate such an effect (Zhang et al. 2011).  
Another example of nanoparticles making their way into medical application is that of iron 
oxides (Li and Chen 2011). These nanoparticles possess superparamagnetic properties 
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which make them invaluable imaging tools, particularly, for example, as contrast agents for 
the widely used magnetic resonance imaging (MRI) (Gupta et al. 2007). Iron oxide 
nanoparticles have passed through clinical trials as contrast agents for the MRI based 
detection of otherwise undetectable metastatic lymph node tumours (Harisinghani et al. 
2003).  
Studies into the toxicities of these nanoparticles remain relatively few in number, and while 
in vivo studies have generally shown that clinical doses of these nanoparticles are non-
toxic, concerns have been raised about certain aspects of the distribution of these 
nanoparticles in vivo that have yet to be addressed (Li and Chen 2011; Kim et al. 2006). 
Toxicity through oxidative stress has been observed as a consequence of the exposure of 
iron oxide nanoparticles to lung cells, dermal cells (in conjunction with exposure to 
environmental levels of ultraviolet radiation) and neuronal cells, particularly in the 
hippocampal region of the brain (Murray et al. 2012; Kim et al. 2006; Ma et al. 2008; Zhu 
et al. 2008).  
A number of investigations into the aforementioned effects of size, route of administration, 
and surface chemistry on the pharmacokinetics and toxicity of gold and iron oxide 
nanoparticles have been performed, however a discussion of these is beyond the scope of 
this introduction (Li and Chen 2011). It is important to note however, that as in the case of 
nanoparticles found in commercial products, there is a need for a more complete 
understanding of the toxicity of biomedical nanoparticles like gold and iron oxide (Li and 
Chen 2011).  
 9 
 
In light of the expanding application of nanoparticles and the potential toxicities of a 
number of these nanoparticles highlighted by recent investigations, there is now an 
increasing awareness of the need for tighter safety legislation to regulate the production of 
nanoparticle based technologies based on an accurate understanding of nanoparticle 
interactions in biological systems and their toxicities (McCall 2011; Weir et al. 2011). 
These safety concerns are not limited to nanoparticles found in commercial and medical 
products however, and extend to NPs generated by industrial and vehicular processes. 
1.3 Nanoparticles and Environmental Exposure 
Investigations into the production of nanoparticles as a byproduct of vehicle exhaust and a 
number of manufacturing processes have revealed that these sources generate a number of 
potentially toxic particles with serious environmental health consequences (Canagaratna et 
al. 2010; Wang et al. 2011).  
Emissions from both diesel and gasoline based vehicles are now known to be rich in 
nanoparticles (Sakurai et al. 2003; Tobias et al. 2001). Analysis of the nanoparticles found 
in these emissions has shown that they are largely highly volatile organic particles around 
50nm in size formed from unburned fuel and lubricating oil, as well as a small number of 
sulfuric acid nanoparticles (Fushimi et al. 2011; Sakurai et al. 2003; Tobias et al. 2001). 
Similarly a number of widely used manufacturing processes like heat treatment, threading, 
high speed machining, and welding have been shown to generate nanoparticles (Heitbrink 
et al. 2007; Thornburg et al. 2000; Wang et al. 2011).  These processes make use of semi-
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volatile mineral oil-based metalworking fluids (MWFs) which are thought to form 
nanoparticles as a consequence of the heating of these fluids in manufacturing settings 
(Thornburg and Leith 2000). 
Nanoparticles generated by vehicles and industrial processes contribute significantly to the 
increasing presence of ambient particulate matter (PM) in the environment, a factor which 
has been shown to pose a significant toxicological concern particularly due to exposure to 
the respiratory tract (Figure 4) (Li, Xia, and Nel 2008). Exposure to PM has been identified 
as a causative factor in incidences of cardiovascular and pulmonary disease, and thus far 
oxidative stress is thought to be the major mechanism by which nanoparticles in the 
environment cause disease and mortality (Grahame and Schlesinger 2012; Ayres et al. 
2008; Li, Xia, and Nel 2008).  
 
Figure 4 Ambient particulate matter, a by-product of industrial and vehicle 
processes, includes a diverse range of particles of different sizes, shapes, and 
compositions. Amongst these are nanoparticles, which distribute to alveoli and 
elements of the distal respiratory system and can cause incidences of serious 
pulmonary disease. (BeruBe et al. 2007). 
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1.4 Nanoparticles in Physiological Environments and the Protein Corona 
Upon exposure to physiological environments, nanoparticles develop a distinct biological 
identity which dictates their behaviour within that particular milieu (Figure 5) (Walkey and 
Chan 2011; Nel et al. 2009). This biological identity involves the formation of a protein 
corona around nanoparticles exposed to specific media such as serum or plasma (Nel et al. 
2009).  
This corona has been shown to dictate diverse elements of the in vivo and in vitro response 
to nanoparticles, including uptake, plasma membrane binding, transport, aggregation, and 
toxicity (Walkey and Chan 2011; Nel et al. 2009). Therefore an understanding of the 
formation of the protein corona and its consequent effects is absolutely critical to 
Figure 5 Figure illustrating the 
distinction between the synthetic 
identity of nanomaterials and the 
biological identity assumed once 
within biological media. While the 
many physical and chemical 
properties of nanoparticles drive 
adsorption events which form 
distinctive protein coronas, it is the 
corona and the unique biological 
identity it confers to nanomaterials 
in biological environments that 
affects interactions with cells both 
in vitro and in vivo. The corona is 
key to the physiological response to 
nanoparticles, and can affect 
absorption, distribution, and 
clearance (Image from Walkey and 
Chan 2011).  
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effectively developing nano-therapies with controlled physiological absorption and 
distribution kinetics, as well as understanding the toxicity of nanoparticles present in the 
environment (Sanfins et al. 2011).  
1.4.1 Mechanisms and Kinetics of Corona Formation  
The current understanding of the mechanisms and kinetics of corona formation is that the 
binding energies of adsorption events (Figure 6), and hence their thermodynamic 
favourability, is dependent on protein structure and the physicochemical properties of the 
nanoparticles themselves (De et al. 2007).  
Energetically favourable changes include covalent and non-covalent bonding, as well as 
conformational changes (in either protein structure or the surface of the nanoparticles in 
question) (Walkey and Chan 2007).  
Figure 6 Equation describing the binding energy of adsorption events. Here ΔGads is the 
change in Gibbs Free Energy (the binding energy of an adsorption event), ΔHads is the change 
in enthalpy during adsorption, T is temperature, and ΔSads is the change in entropy that occurs 
during adsorption (Walkey and Chan 2011). 
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The stability of protein-nanoparticle binding is dependent on the binding energy of the 
adsorption event involved (Walkey and Chan 2007; Casals et al. 2010). Generally, proteins 
with large binding energies remain associated with nanoparticles over longer periods of 
time, and form what is referred to as the ‘hard corona’, while proteins that adsorb with low 
binding energies form a ‘soft corona’ which is easily desorbed back into solution (Figure 7) 
(Casals et al. 2010).  
The binding energy of each adsorption event is determined by the structural composition of 
proteins and the physicochemical properties of the nanoparticles with which they are 
interacting (De et al. 2007). For instance, nanoparticles with charged surfaces are likely to 
form stable bonds with hydrophilic proteins (De et al. 2007).  
Figure 7 In this figure the formation of a distinctive 
protein corona around nanoparticles is modeled in terms 
of adsorption and desorption constants. The corona is 
currently thought to be comprised of two distinct 
elements in terms of adsorption/desorption rates and 
binding energies, and these are the soft and hard corona. 
The hard corona is typified by high binding energy 
adsorption events of high affinity proteins that associate 
closely with the surface of nanomaterials, while the soft 
corona is thought to be comprised of lower affinity 
proteins which adsorb via protein-protein interactions. 
Kon is the association constant, while Koff is the 
dissociation constant. Kon is dependent on both the 
binding affinity of a protein (and hence the likelihood of 
a binding event) and the concentration of said protein. 
Koff is based on the binding energy of the adsorption 
events (Image adapted from Walkey and Chan 2011). 
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The induction of conformational changes during corona formation has important 
consequences on interactions between nanoparticles possessed of a corona and their 
physiological environment (Shang et al. 2007; Mahmoudi et al. 2011). These 
rearrangements can expose domains and sequences that would not otherwise be available 
for interactions, and as such can have significant consequences on the pharmacokinetics of 
nanoparticles in vivo (Shang et al. 2007). Moreover these newly bared moieties can result 
in protein-protein interactions which may further alter the composition of the protein 
corona (Mahmoudi et al. 2011).  
In a study into the kinetics of corona formation, Cedervall et al. (2007) generated a model 
in which proteins were divided into groups according to their rates of association and 
dissociation to the copolymer nanoparticles used by the authors (Figure 7).  
The first group was characterised by rapid adsorption (within seconds) associated with the 
formation of a stable hard corona, which was also shown to demonstrate slow desorption 
(over a period of hours) (Cedervall et al. 2007). Conversely the second group demonstrated 
a slow rate of association and rapid dissociation reflective of the low affinity binding of the 
soft corona (Cedervall et al. 2007).  
Protein adsorption, and hence corona formation, is a highly dynamic process in the context 
of nanoparticles in physiological environments (Casals et al. 2010; Sanfins et al. 2011). 
The association and dissociation of various proteins over time is referred to as the Vroman 
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Effect, which states that the composition of the corona can change over time while the total 
protein content remains relatively unchanged (Sanfins et al. 2011; Casals et al. 2010).  
Interestingly in the context of physiological media the abundance of proteins strongly 
affects initial binding events, and it has been shown that the early stages of the Vroman 
Effect in plasma will involve the rapid binding of low affinity but highly abundant proteins 
like albumin and Immunoglobulin G (Dell’Orco et al. 2010). These are rapidly displaced 
by high affinity molecules like apolipoproteins within seconds (Dell’Orco et al. 2010; 
Casals et al. 2010). This illustrates the complexity of the kinetics of protein corona 
formation, which is dictated by a number of factors that are closely interlinked.  
Protein binding to nanoparticles can result in a conformational change provided that such a 
change would allow for an energetically favourable interaction between either charged or 
hydrophobic regions of the nanoparticles and the proteins in question (Gessner et al. 2000).  
Whether such conformational changes are induced during adsorption also depends on other 
physicochemical properties of both nanoparticles and proteins involved, for example 
proteins with disulfide bonds or other strong internal bonds are less likely to undergo a 
conformational change (Walkey and Chan 2011).  
1.4.2 Composition of the Corona  
Investigations into the composition of the protein corona to date show that the protein 
corona is complex and highly individual to the nanomaterials in question and the media in 
which they are found (Walkey and Chan 2011). Analyses of protein coronas on a number of 
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different nanoparticles have revealed that approximately 125 different proteins with varying 
physiological roles can adsorb onto the surface of various nanomaterials and form part of a 
unique and distinctive protein corona.  
The physicochemical composition and surface chemistry of nanoparticles have been shown 
to be major determining factors in the formation of a distinct protein corona, and hence the 
fate of nanoparticles both in vivo and in vitro (Walkey et al. 2011; Sanfins et al. 2011; Nel 
et al. 2009). Other characteristics of nanoparticles that dictate their interactions with 
biological materials include shape, hydrophobicity or hydrophilicity, surface architecture 
(crystallinity or heterogeneity), aggregation, and zeta potential (Verma and Stellaci 2010; 
Patil et al 2007).   
The role these properties have to play in corona formation is demonstrated by a body of 
proteomic studies which illustrate the depth and diversity of proteins involved in corona 
formation (Figure 8), and how the properties of various nanomaterials influence the 
composition of the corona (Lundqvist et al. 2008; Deng et al. 2009). In an analysis of the 
corona formed on 50nm and 100nm polystyrene nanoparticles with different surface 
charges (positive, negative, and uncharged), Lundqvist et al. (2008) found that both size 
and charge influence which proteins bind to form the corona.  
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Figure 8 In a review of the literature to date, Walkey and Chan (2011) compiled an 
adsorbosome of 125 proteins reported as elements of the protein corona in 26 separate 
studies into corona composition. In this figure the detection of key proteins of interest are 
represented in terms of the percentage of studies in which they are observed. Interestingly 
Apolipoprotein A-1, despite its relatively low abundance when compared to other plasma 
proteins, is detected in approximately 90% of the 26 studies reviewed. While Ig Gamma 
and Light Chains are observed across a range of nanomaterials, the Heavy Chain 
Immunogobulin is detected in a relatively small number of such studies (Adapted from 
Walkey and Chan 2011). 
For example, the authors found that apolipoproteins were a major part of the corona formed 
on positively charged (amine modified nanoparticles), whereas these lipoproteins were 
barely present on negatively charged (carboxylate modified) NPs (Lunqvist et al. 2008). In 
some cases these differences were remarkably specific, as demonstrated by apolipoprotein 
B-100 which did not bind to 50nm particles regardless of surface chemistry, and yet was 
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found in abundance on 100nm NPs of all three surface charges tested (positive, negative, 
and neutral) (Lundqvist et al. 2008).  
In a comparison of three metal oxide nanoparticles (titanium dioxide, zinc oxide, and 
silicon dioxide) with the same surface charge Deng et al. (2009) showed that these factors 
strongly affected which proteins bound these nanoparticles, and hence the composition of 
the corona. The authors found that while very similar proteins contributed to the corona of 
titanium and silicon dioxide particles, zinc oxide nanoparticles adsorbed markedly different 
proteins (Deng et al. 2009).  
The authors found that certain proteins (e.g. Clusterin, Apolipoprotein D, and Alpha-2-acid 
glycoprotein) would adsorb to titanium and silicon dioxide particles and yet were not 
detected on zinc oxide (Deng et al. 2009). Interestingly the reverse was also true, and 
proteins like Transferrin, Ig Heavy Chain Alpha, and Haptoglobin (alpha) were found 
bound to zinc oxide nanoparticles alone (Deng et al. 2009).  
Deng et al.  (2009) also investigated the impact of shape on protein binding to titanium 
dioxide nanoparticles, and found a similar pattern of exclusivity in certain cases. Clusterin 
and Apolipoprotein D for example would only bind to spherical nanoparticles, and were not 
found associated with nanorods or –tubes (Deng et al. 2009).  
These examples should illustrate the fact that the composition of the protein corona varies 
in response to a number of different nanoparticle properties (Deng et al. 2009; Lundqvist et 
al. 2008). However as more investigations into corona composition are performed some 
 19 
 
patterns of adsorption are emerging. The binding of apolipoproteins for example, has been 
shown to be an essential part of the formation of a stable hard corona on hydrophobic 
nanoparticles (as a consequence of interactions between hydrophobic surfaces and the lipid 
binding domain possessed by apolipoproteins) (Gesner et al. 2000; Cedervall et al. 2007). 
On the other hand, IgG, Fibrinogen, and Albumin typically adsorb on to the surfaces of 
hydrophilic nanoparticles preferentially (Gesner et al. 2000; Cedervall et al. 2007). 
Beyond the properties of NPs themselves, the composition of the biological media in which 
they are found is key in determining the formation of a protein corona, and subsequently 
the interactions between those nanoparticles, now possessed of a distinct biological 
identity, and cellular materials (Nel et al. 2009). This is an area which has yet to be 
thoroughly investigated, and is an important aspect of the study reported here.  
1.5 Previous Work and Aims of Study 
Previous work in this lab conducted by Smith et al. (2012) revealed a serum-sensitive 
pathway of carboxylate modified polystyrene nanoparticle binding and uptake to and into 
HeLa cells. The authors found that when comparing nanoparticle interactions with cells in 
serum free and 10% serum containing media, twenty-fold inhibition was observed in the 
latter across a number of different time courses (Figure 9) (Smith et al. 2012). Furthermore, 
a three-fold reduction in zeta potential was observed when comparing serum free 
(approximately -32mV) and serum containing media (approximately -10mV) (Smith et al. 
2012). 
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These findings suggested that the inhibitory effect of serum on the binding and uptake of 
polystyrene nanoparticles by HeLa cells could potentially be a consequence of a reduction 
in surface charge caused by the formation of a protein corona (Smith et al. 2012). Therefore 
with these findings in mind, this study aims to further investigate the relationship between 
serum, surface charge (measured by zeta potential), and nanoparticle interactions with the 
plasma membrane.  
The importance of surface charge as a factor influencing nanoparticle interactions with 
Figure 9 Image demonstrating differences in zeta potential and cell-associated nanoparticle signal 
in serum containing and serum free media. A and B) Cell-associated nanoparticle fluorescence 
measured over a 120 minute time course. A twenty-fold reduction in signal was observed, and was 
reproduced in C) MDCK cells. D) Three-fold reduction in zeta potential due to the presence of 
serum (Smith et al. 2011).  
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biological media has been well established, and as such this study investigated particles 
with the same surface carboxylate modification as Smith et al. (2012) to allow for an 
accurate and comparable investigation into the effects of different serum concentrations 
(Nel et al. 2009). Size is another variable that has been shown to strongly affect 
nanoparticle behaviour, and while particles of the same diameter as those previously 
reported by Smith et al. (2012) were investigated (20nm), 200nm and 1µm carboxylate 
modified polystyrene particles were also investigated to explore the effects of size on the 
serum induced reduction of particle-cell interactions and surface charge.  (Jiang et al. 2008; 
Walkey et al. 2012) 
Furthermore, Bovine Serum Albumin (BSA), the most abundant protein in serum and 
plasma, was investigated to ascertain whether or not this protein could induce similar 
effects on membrane-nanoparticle interactions and zeta potential (Chakraborty et al. 2011).  
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SECTION 2: MATERIALS AND METHODS 
 
2.1 Cell Culture 
The experiments reported in this study were performed on HeLa cells (Health Protection 
Agency Culture Collections, Salisbury, United Kingdom) incubated with 5% carbon 
dioxide at 37 C. Cells were grown in 75cm2 cell culture flasks (Contig) with serum 
containing media composed of 10% Foetal Bovine Serum (BioSera), 1% penicillin and 
streptomycin (Invitrogen), and Dulbecco’s Modified Eagle Medium (DMEM) (Lonza). 
For passaging and plating for the experiments described herein cells were first detached by 
incubation with trypsin (Invitrogen) for 5 minutes at 37 C, then re-suspended in serum 
containing media described above. This suspension was then placed into new flasks and 
diluted appropriately, or onto the plates relevant to the experiment to be performed (96 well 
plates for plate reader experiments (Section 2.3) and onto 22mm coverslips housed on six-
well plates for wash experiments (Section 2.5)).  
2.2 Nanoparticles Used 
The nanoparticles used in this study were carboxylate modified fluorescent yellow/green 
polystyrene FluoSpheres (Invitrogen). Particles at 20nm, 200nm, and 1µm diameters were 
used, and these were provided in suspensions at 2% solids with water and 2mM sodium 
azide.  
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The concentration of nanoparticles of these sizes used in this study was scaled (taking 
account the number of particles in suspension) so that the same total surface area was 
available for adsorption, thereby allowing for comparability between studies performed on 
particles of different sizes. Using the formula provided by Invitrogen (Figure 10), it was 
determined that to match the total surface area of 20nm particles in 2% suspensions at a 
1:1000 dilution, a 1:100 dilution of 200nm particles and a 1:200 dilution of 1µm particles 
would be needed.  
2.3 Plate Reader Experiments 
To determine nanoparticle binding to the plasma membrane, carboxylated polystyrene 
FluoSpheres of varying diameters were incubated with HeLa cells for 15 minutes with 
varying concentrations of either Foetal Bovine Serum (FBS) or Bovine Serum Albumin 
(BSA) (Sigma). 0%, 0.05%, 0.25%, 1%, 2.5%, 5%, and 10% concentrations of FBS were 
used and each concentration tested in triplicate three times (n = 3. Equivalent 
concentrations of BSA were used made from a stock solution of BSA at a concentration of 
Figure 10 Formula for the deduction of the total number of FluoSpheres present in a given 
volume of suspension provided by Invitrogen and used to determine the concentrations of 
20nm, 200nm, and 1µm particles at which total surface area would be constant (Image from 
Invitrogen).  
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15.4 g/l, the amount of BSA reported by BioSera to be present in FBS. This allowed for 
comparable data points at which the amounts of BSA present were equivalent to those in 
FBS. The polystyrene FluoSpheres used were incubated with HeLa cells for 15 minutes, as 
it this point these particles are largely bound to the plasma membrane as illustrated by 
Figure 11, therefore allowing the plate reader data to be interpreted as a measure of 
nanoparticle binding to the cell surface. 
Cells were detached with trypsin as per the method described in Section 2.1 prior to plating 
in uClear black 96-well glass bottomed plates (Greiner Bio) and incubation for 
approximately 24 hours at 37 C in the presence of 5% carbon dioxide. Cells were then 
serum starved for 15 minutes in DMEM, before being treated with 100µl of the relevant 
concentrations of either BSA or FBS and FluoSpheres at diameters of either 20nm, 200nm, 
Figure 11 Confocal microscope images illustrating the binding of 20nm carboxylate modified 
yellow/green polystyrene nanoparticles to the plasma membrane of a HeLa after a 15 minute 
incubation. This point in time was chosen as the focus of the plate reader study so that the signal 
detected by the plate reader could be accurately interpreted as membrane associated. A) Shows both 
yellow/green polystyrene nanospheres and DAPI nuclear staining. B) An image using the green 
laser of an inverted A1R Nikon Confocal Microscope scaled for brightness placed next to C) a 
transmitted light image to show that nanoparticles are in fact binding to the plasma membrane.  
A B C 
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or 1µm and incubated for a further 15 minutes at 37 C.  
After this incubation the treatment solution was removed and cells were washed twice with 
100µl of phosphate buffered saline (PBS) (Lonza) before fixing with 100µl of 4% 
paraformaldehyde (PFA) for 5 minutes at room temperature (Electron Microscopy 
Sciences). Post-fixation the PFA solution was removed and cells rinsed a further two times 
with 100µl PBS. Analysis of these treated samples was then performed with cells in 100µl 
PBS using a FLUOStar Omega Fluorescence Plate Reader (BMG LABTECH GmbH). 
2.4 Zeta Potential Measurements 
Zeta potentials of 20nm, 200nm, and 1µm Carboxylated FluoSpheres in different 
concentrations of FBS and BSA were determined using the Malvern Zetasizer Nano ZS 
ZEN3600 (Malvern Instruments). 2ml samples of 20nm, 200nm, and 1µm FluoSpheres 
were prepared at the aforementioned concentrations (Section 2.2) in 0%, 0.025%, 0.05%, 
1%, and 10% concentrations of FBS and 15/4 g/l BSA stock solution.  
2.5 Development of Protocol to Remove Membrane Bound Nanoparticles 
As a part of this project an attempt was made to establish a protocol to remove membrane 
bound nanoparticles and allow for the study of nanoparticle internalisation by means of a 
plate reader assay as described in Section 2.3.  
To this end cells were plated in 6-well plates on 22mm glass coverslips for approximately 
24 hours before 15 minutes of serum starvation in 2ml DMEM followed by a 15 minute 
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incubation with 20nm nanoparticles in serum free DMEM at a dilution of 1:1000. The cells 
were then rinsed twice with 2ml of PBS prior to 5 minutes fixation in 1ml of 4% PFA.  
coverslip were then mounted on glass slides with Vectashield (Vector Laboratories Ltd) for 
imaging with the 60x oil objective of a Nikon A1R Inverted Confocal Microscope (Nikon 
Corporation).  
To ensure that images were taken and compared on the same focal plane, slides were 
captured as Z-stacks and the image possessing the broadest DAPI nuclear stains selected as 
the mid-section of the cell.  
After treatment with the nanoparticle solution a number of different wash protocols were 
tried. These included 10 second, 30 second, 60 second, and 90 second trypsin (Invitrogen) 
and Accutase (Invitrogen) washes, as well as a series of Hank’s Balanced Salt Solution 
(HBSS) washes which had been shown by other authors to remove membrane bound 
nanoparticles (Georgieva et al. 2010; Rejman et al. 2004). 
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SECTION 3: RESULTS 
3.1 FluoSphere Binding to the Plasma Membrane in Varying Concentrations of 
Serum as Determined by Plate Reader 
The plate reader data from the serum experiments described in Section 2.3 are presented in 
Figure 12. The plate reader data has been normalised to 1 to better represent the exponential 
decay of membrane associated fluorescent signal as a result of increasing serum 
concentration.  
The data indicates that the inhibitory effect of serum on the binding of carboxylate 
modified polystyrene FluoSpheres is size dependent, with the reduction of membrane 
associated signal at 10% serum 10-fold less for 1µm particles than 20nm nanoparticles, and 
3-fold less for 200nm FluoSpheres when compared to their 20nm counterparts.  
Statistical testing in this study was performed using the Student’s t-test, which allowed for 
a comparison of the raw data between 20nm and 200nm particles and 200nm and 1µm 
particles. This method allows for an accurate comparison between data sets based on the 
actual data reported (Rice 1989).  
The t-tests comparing 20nm nanoparticles to 200nm and 1µm particles found that while the 
1µm data was significantly different to the 20nm data, only 3 data points at 200nm (at 10%, 
2.5%, and 1% serum) were statistically different (Figure 12) when compared to 20nm.  
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Figure 12 Line graph demonstrating the inhibitory effect of different concentrations of serum on carboxylate modified 
yellow/green polystyrene FluoSphere (20nm, 200nm, and 1µm diameters) binding to the plasma membrane after 15 
minute incubations. The graph shows that the inhibitory effect of serum on nanoparticle fluorescence (a measure of 
membrane binding after 15 minutes of incubation) is size dependent, and is dramatically reduced at 1µm when 
compared to 200nm and 20nm. A Student’s t-test revealed that all 1µm data points presented here were statistically 
significant (p-value < 0.05) when tested against the 20nm data, while only three 200nm data points (indicated by 
asterisks) were significantly different (p-value < 0.05) when compared to 20nm data. (Error bars indicate standard error 
of the mean). 
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3.2 Polystyrene FluoSphere Zeta Potentials in Serum  
While the plate reader showed an exponential decline in membrane-associated FluoSphere 
signal, the zeta potential data illustrated by Figure 13 shows a rapid decrease in zeta 
potential at the lowest concentrations of serum (0.025%) for all three sizes of polystyrene 
FluoSpheres studied. The reduction in zeta potential plateaus sharply between 0.05% and 
1% and the total 3-fold reduction in zeta potential is achieved at approximately 1%, 
whereas membrane binding as demonstrated by the plate reader data in Figure 11 of 
particles of all three sizes continues to decline and does not reach a saturation point even at 
10%.  
Figure 13A represents the raw zeta potential data and there is an observable and statistically 
significant difference between each data set. The instrument measures zeta potentials via 
electrophoretic motility, and so as the trends evidenced by each data set are similar the 
differences in zeta potential magnitude can potentially be attributed to the fact that 
differently sized particles will have different motilities in suspension (O’Brien, Cannon, 
and Rowland 1995).  
To determine whether or not the differences observed between each data set were due to 
size-dependent variations in motility, and hence zeta potential measurement, a second 
graph (Figure 13B) is included in which the data illustrated in Figure 12A has been 
normalised to 1.  Interestingly t-testing the normalised data showed that the only the 
0.025% and 0.05% data points of 1µm and 200nm measurements were statistically 
significantly different to their 20nm equivalents. 
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Figure 13 A) Graph illustrating the raw zeta potentials of 20nm, 200nm, and 1µm carboxylate 
modified yellow/green polystyrene FluoSpheres in varying concentrations of serum. The 
introduction of even small concentrations of serum results in a sharp decrease in the measured zeta 
potentials of particles of all three sizes. All differences between 20nm and 1µm and 20 nm and 
200nm FluoSpheres were shown to be statistically significant by a Student’s t-test. While this trend 
is comparable across all three data sets, the magnitude of the zeta potentials recorded varies by 
particle size, which may be attributable to the effect of size on electrophoretic motility (from which 
zeta potential is calculated). B) Normalised zeta potential data plotted to demonstrate the similarity 
in trends between the differently sized FluoSpheres tested. Here differences between 20nm and 1µm 
and 20nm and 200nm particles at 0.025% and 0.05% were statistically significant (p-values < 0.05). 
(Error bars indicate standard error of the mean). 
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3.3. Plate Reader Bovine Serum Albumin (BSA) Data 
As shown by Figure 14, BSA does not inhibit the binding of polystyrene FluoSpheres to the 
plasma membrane to the same extent as serum. 20nm carboxylate modified particles only 
demonstrated a 4-fold reduction in binding, while 200nm and 1µm showed an 
approximately 1.6-fold inhibition (Figure 14). This is also illustrated by Figure 15 which 
directly compares 20nm nanoparticles in serum and BSA and clearly illustrates the 
substantial difference between the two data sets.  
Figure 14 Graph demonstrating the effect of different concentrations of BSA, prepared in quantities 
equivalent to those found in similar concentrations of serum, on the membrane binding of 20nm, 
200nm, and 1µm carboxylate modified polystyrene FluoSpheres. Between 0% and 10% there is a 
size dependent reduction in the observed membrane associated nanoparticle fluorescence, however 
at lower concentrations there is a reproducible, if not statistically significant, increase in membrane 
binding. In a comparison between 20nm data and 200nm and 1µm using the Student’s t-test, only 
data at 1% and 10% BSA were found to be statistically significant (p-values < 0.05). 
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Interestingly an increase in FluoSphere binding was observed at low concentrations of 
BSA. However this increase, while reproducible and evident in each of the three sizes  
tested, was not statistically significant when compared to values at 0% using a Student’s t-
test. Furthermore when comparing the 20nm to 200nm and 1µm data using the same test 
statistically significant differences were observed only at 1% and 10% BSA. 
3.4 Zeta Potentials in BSA 
As shown in Figure 16, there is an exponential reduction in zeta potential (ZP) caused by 
the presence of BSA. As in the case of the serum data (Figure 12), the change in zeta 
Figure 15 Graph comparing the reduction in plasma membrane associated fluorescence of 20nm 
carboxylate modified yellow/green polystyrene nanoparticles in the presence of different 
concentrations of serum and bovine serum albumin (BSA) at 15.4 g/l, a concentration equivalent to 
the amount of the protein found in serum. The graph shows that while BSA causes a reduction in 
the plasma membrane associated nanoparticle associated fluorescence, it is not equivalent to the 
serum effect. At low concentrations of BSA 20nm polystyrene nanoparticles exhibit an increase in 
plasma membrane binding which is not statistically significant when compared to the signal at 0% 
BSA (p < 0.05%) after t-testing. (Error bars indicate standard error of the mean). 
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potential is not size dependent and when normalised (Figure 16B), and only one data point 
(0.05%) is significantly different (p-value < 0.05) when 200nm and 1µm particles are 
compared to 20nm data using a Student’s t-test.  
However when compared to the zeta potentials measured in serum, the magnitude of this 
change and the rate at which it occurs is markedly different. Where a 3-fold change in zeta 
potentials was observed between 0% and 10% serum, 10% BSA at a concentration 
equivalent to the quantities of the protein found in serum (15.4g/l) only induced a 2-fold 
reduction in ZP (illustrated in the case of 20nm particles by Figure 17). 
The 20nm zeta potential data also showed a statistically significant increase in zeta 
potential at 0.05% BSA which corresponds to the increase in plasma membrane binding 
observed in the plate reader data (Figure 14).  
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Figure 16 A) Raw zeta potential data for 1µm, 20nm, and 200nm carboxylate modified 
yellow/green polystyrene FluoSpheres in serum equivalent concentrations of Bovine Serum 
Albumin (BSA). The data shows an exponential decay in zeta potential for all three particles tested. 
B) Normalised zeta potential data shows that the reduction in zeta potential is uniform across all 
three sizes, and the only statistically significant data point (after a t-test to compare 20nm data with 
200nm and 1µm measurements) is at 0.05%. (Error bars indicate standard error of the mean). 
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3.5 Washes to Remove Membrane Bound Polystyrene Nanoparticles 
As described in Section 2.5, a number of different methods were used to attempt to remove 
plasma membrane bound nanoparticles. The successful removal of all surface bound 
fluorescence would allow for the accurate quantification and study of nanoparticle 
internalisation under different conditions and contribute to an improved understanding of 
the mechanisms of nanoparticle entry into cells in the context of different biological media.  
Unfortunately none of the attempted protocols successfully removed all of the surface 
bound 20nm carboxylate modified yellow/green polystyrene nanoparticles. The results of 
the most successful attempt are shown in Figure 18, where a series of successive 5 minute 
Hank’s Balanced Salt Solution (HBSS) and 30 second Accutase washes were used. 
Figure 17 Graph comparing the reduction in zeta potentials (normalised) of 20nm carboxylate 
modified yellow/green polystyrene nanoparticles in the presence of different concentrations of 
serum and bovine serum albumin (BSA). The concentrations of BSA reported are in proportion to 
the amounts of BSA found in equivalent concentrations of serum, therefore 2% BSA is equivalent 
to the amount of BSA found in 2% serum. A) The graph shows that while BSA causes a reduction 
of Zeta potential, the magnitude of this change is not equivalent to the reduction in zeta potential 
induced by serum (all results statistically significant with p < 0.05). (Error bars indicate standard 
error of the mean). 
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Figure 18 Confocal microscopy 
images of cells treated with a 
1:1000 dilution of 20nm 
carboxylate modified yellow/green 
polystyrene nanoparticles in serum 
free Dulbecco’s Modified Eagle’s 
Media (DMEM) for 15 minutes. 
Images A1-3 represent control 
cells which show that at 15 
minutes nanoparticles are bound to 
the plasma membrane. A1 shows 
cells with both green (polystyrene 
nanoparticles) and blue (DAPI 
nuclear stain signal), while A2 
shows the same image on the 
green filter scaled for brightness. 
A3 is a transmitted light image for 
comparison. Images B1-3 show 
cells treated with nanoparticles as 
in A which were then treated with 
4 successive 5 minute Hank’s 
Balanced Salt Solution (HBSS) 
and 30 second Accutase washes. 
Images B1 and B2 show 
significantly reduced fluorescence 
from membrane bound 
nanoparticles when compared to 
the control images (A1 and A2), 
however some membrane 
associated signal remains. 
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SECTION 4: DISCUSSION 
4.1.1 Membrane Binding and Zeta Potentials in Serum 
The effect of serum on nanoparticle binding to the plasma membrane was found to be 
dependent on serum concentration and the size of the polystyrene FluoSpheres used. For all 
three sizes of carboxylate modified polystyrene particles studied, the membrane associated 
signal decreased in response to an increasing concentration of serum. This effect was 
diminished as the polystyrene FluoSpheres increased in size, with 20nm nanoparticles 
showing the greatest sensitivity to the inhibitory effect of serum, while 200nm and 1µm 
particle binding to the plasma membrane were successively less affected.  
The reduction in membrane binding caused by serum is attributed to the formation of a 
protein corona around nanoparticles, and size has been shown to be an important factor in 
driving both the composition and kinetics of protein binding to nanoparticles (Jiang et al. 
2008; Walkey et al. 2012).  This data further supports existing evidence that shows that 
particle size strongly influences the formation of a protein corona, and its consequent 
inhibition of interactions between nanoparticles and cells (Walkey et al. 2012). Moreover 
the fact that there is a clear relationship between membrane binding and the concentration 
of serum indicates that protein abundance is also an important factor in corona formation 
and the resultant effects on nanoparticle-plasma membrane binding.  
Interestingly the zeta potential data presented in this study showed that size had no 
significant effect on the reduction of surface charge caused by the formation of a protein 
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corona. All three sizes tested in this study exhibited the same sharp decrease in zeta 
potential at low concentrations of serum, an effect which plateaued rapidly in contrast to 
the plasma membrane binding data which showed a much smaller decay constant, and did 
not reach saturation even at the highest tested concentration of serum (10%).  
The homogenous change in zeta potential observed between particles of different sizes 
could be attributed to the fact that the concentrations of the differently sized nanoparticles 
used were scaled to ensure that the total available surface area for protein interactions was 
constant. 
The zeta potential data reported in this study suggests that at approximately 1% serum 
(above which surface charge remains relatively constant) there is sufficient material in the 
test solutions to form a stable corona, and that the total quantity of nanoparticle bound 
protein remains constant despite the increase in serum, and hence protein, concentration. 
The plate reader data however shows that the inhibitory effect of serum on nanoparticle-cell 
interactions continues to increase above 1%, and does not reach a saturation point even at 
the highest test concentration.  
In light of the current model of corona formation described by the Vroman Effect (Section 
1.5.1), it can be hypothesised that while above 1% the total quantity of protein forming the 
corona remains constant, the composition of the corona in terms of the identity of the 
proteins bound continues to be affected by the changing abundance of protein in the test 
solutions (Sanfins et al. 2011; Casals et al. 2010).   
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This hypothesis is supported by a study performed by Monopoli et al. (2011) into the 
effects of varying concentrations of plasma on the composition of the protein corona. The 
authors found that the proteins making up the corona in these different conditions would 
vary. This suggests that protein abundance in biological media impact the kinetics of their 
adsorption onto nanoparticles, and hence, the composition of the corona formation and any 
consequent physiological response (Monopoli et al. 2011).  
While the importance of size, shape, and surface chemistry on corona formation has been 
clearly illustrated, the role that variations in biological media in terms of, for example, 
protein abundance, has yet to be sufficiently investigated (Nel et al. 2009; Walkey and 
Chan 2011). This is a particularly relevant area of study in light of the fact that there are 
diverse biological media to which nanoparticles can be exposed in vivo. For example, 
particulate matter in the atmosphere would be exposed to mucosa in the respiratory tract, 
while nanoparticles administered medically are more likely to be exposed to plasma 
(Abdelhalim and Jarrar 2012). 
Similarly understanding how variations in physiological environments affect nanoparticle 
behaviours in vivo is particularly relevant to designing and administering nanotherapies 
(Petros and DeSimone 2010). Understanding variations in corona formation dependent on 
the media to which nanoparticles are exposed could inform clinical decisions regarding 
routes of administration which would ultimately affect the effectiveness of such therapies 
(Petros and DeSimone 2010).  
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4.1.2 Future Work  
As discussed in Section 4.1.1, the zeta potential and plate reader data reported in this study 
suggest that while a stable corona forms around nanoparticles at approximately 1% 
(resulting in the observed stable reduction in zeta potential), the composition of said corona 
changes in response to further increases in serum concentration. To investigate this 
hypothesis, further work establishing which proteins form the corona at different 
concentrations of serum is needed. Proteomic approaches like mass spectroscopy have 
proven to be powerful tools in determining which proteins bind nanoparticles in biological 
solutions (Lundqvist et al. 2008).  
Surface charge has been shown to be one of the main factors driving protein binding and 
corona formation (Patil et al. 2007; Casals et al. 2010). As such further study into the 
effects of serum into positively charged polystyrene particles would provide further insight 
into the role of charge in nanoparticle interactions with plasma membranes and serum 
proteins. Similarly, investigating particles of equivalent size and surface chemistry but 
differing physicochemical composition (e.g. gold or iron oxide) would demonstrate whether 
composition plays as significant a role in protein interactions in serum as surface chemistry 
and size (Deng et al. 2009).  
Plasma and mucosa are two physiological fluids to which nanoparticles are exposed both as 
potentially harmful agents in the atmosphere and as medical vehicles for treatment, and as 
such characterising their effects on particles of different sizes is an important aspect of 
modelling how nanoparticles behave in vivo (Hyun et al. 2008; Monopoli et al. 2011). As 
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such investigations into the effects of these media at varying concentrations on 
nanoparticle-cell interactions and surface charge could be interesting and highly relevant 
areas of study.  
Similarly studying these effects in tissue types relevant to routes of exposure is also 
important to understanding nanoparticle-cell interactions in the context of their use and real 
life exposure (McCall 2011). Primary cell types like lung epithelium and liver cells are 
good examples of important tissue types to which nanoparticles would be exposed, and 
reproducing the effects reported in this study in these cell types would make this work more 
relevant to existing toxicological concerns (Abdelhalim and Jarrar 2012; Limbach et al. 
2007).  
4.2.1 Membrane Binding and Zeta Potentials in Bovine Serum Albumin  
The plasma membrane binding and zeta potential experiments were repeated in Bovine 
Serum Albumin (BSA), the most abundant protein in serum and in human plasma, to 
determine whether the inhibitory effect of serum on nanoparticle-plasma membrane binding 
could be reproduced with BSA alone. The data shows that while a size- and concentration 
dependent reduction in both membrane binding and surface charge are evident, this change 
is not of the same magnitude as the serum induced effect.  
This finding is particularly relevant in terms of experimental design as a number of recently 
published studies use BSA in isolation in studies modelling protein adsorption and corona 
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formation. Patil et al. (2007) for example investigate the effects of biological media on the 
uptake and surface charge of cerium oxide using BSA solutions.  
This use of BSA is based on the assumption that as the most abundant protein in plasma 
and serum, albumin plays a key role in the formation and effects of the protein corona. This 
is supported by proteomic studies conveniently summarised by Walkey and Chan (2011) 
(Figure 8) who show that 24 of 26 investigations quantifying the composition of the corona 
detected albumin in the protein corona.  
However, as the data reported in this study shows, the effects of BSA on surface charge and 
polystyrene nano- and microsphere binding to the plasma membrane are not directly 
comparable to the effects of serum in equivalent conditions.  
A reproducible but not statistically significant increase in membrane binding was observed 
at low concentrations of BSA for all three polystyrene FluoSpheres tested. Interestingly a 
statistically significant increase in zeta potential was observed when 20nm polystyrene 
nanoparticles were immersed in 0.05% BSA. This effect was not observed at any other 
concentration or particle size.  
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Particular concentrations of plasma and serum have been shown to stabilise certain 
nanomaterials in biological media, causing them to disaggregate and thereby making more 
binding sites available for cell interactions (Wiogo et al. 2011; Monopoli et al. 2011). This 
effect has been shown by Wiogo et al. (2011) who found that magnetic iron oxide particles 
in high concentrations of Foetal Bovine Serum (FBS) disaggregated to yield particles with 
a significantly smaller hydrodynamic diameter than controls (Figure 19).  
This phenomenon has thus far proven to be nanomaterial dependent as it has not been 
observed in sulfonated polystyrene nanoparticles in a study by Monopoli et al. (2011) into 
the effects of varying plasma concentrations on corona formation.  
One of the major concerns in the area of designing nanomaterials for biomedical use is 
aggregation in vivo (Wiogo et al. 2011). Large aggregates can potentially induce an 
immune response, reducing the circulation time of drug delivery vectors (Fukumori and 
Figure 19 Image showing the average 
hydrodynamic diameter of magnetic iron 
nanoparticles in a number of different 
media. The lowest hydrodynamic diameter 
observed was in a) water, f) 4%, g) 8%, and 
h) 10% Foetal Bovine Serum (FBS). At 
these concentrations FBS stabilised the iron 
nanoparticles tested, causing them to 
disaggregate. At lower concentrations of 
FBS (c) 0%, d) 1%, e) 2% FBS) and in b) 
phosphate-buffered saline (PBS) particles 
would aggregate resulting in the large 
hydrodynamic radius observed by dynamic 
light scattering (DLS) (Image from Wiogo 
et al. 2011).  
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Ichikawa 2006). Particularly large aggregates in the region of 4µm diameters can also 
potentially cause the blockage of fine blood capillaries (Neuberger et al. 2005). As Wiogo 
et al. (2011) have shown however, it is possible to stabilise particular nanomaterials via the 
adsorption of BSA and the subsequent disaggregation of particles. The magnetic 
nanoparticles tested by Wiogo et al. (2011) remained in a disaggregated state once 
immersed in biological media after treatment with BSA, suggesting that this method is a 
potential solution to the problem of unwanted aggregation in vivo. 
In this study we have observed a trend which indicates that particular concentrations of 
BSA can stabilise polystyrene FluoSpheres of various sizes, and that the stabilising effect 
of BSA observed by Wiogo et al. could potentially be reproduced in other nanomaterials.  
4.2.2 Future Work  
As discussed in Section 4.2, an increase in plasma membrane associated signal was 
observed at low concentrations of BSA, an effect which can potentially be attributed to a 
previously observed ‘stabilising’ effect of protein corona which can cause particle 
disaggregation (Wiogo et al. 2011).  
To test this hypothesis reliable sizing data would be needed to determine whether the 
increase in plasma membrane binding correlates to a disaggregation of polystyrene 
FluoSpheres at low concentrations of BSA. While Dynamic Light Scattering (DLS) has 
traditionally been used for nanoparticle sizing, its use is more appropriate for 
 45 
 
monodispersed samples where an average hydrodynamic diameter is reflective of 
individual particle sizes (Poda et al. 2011).  
In this instance the presence of aggregates of different sizes warrant the use of a technique 
like Field Flow Fractionation (FFF), which separates a suspension of nanoparticles 
according to size to yield data on the differently sized aggregates present in a particular test 
solution (Poda et al. 2011). Investigating the sizes of aggregates at low concentrations of 
BSA would prove an effective way to test the hypothesis that these amounts of protein can 
cause the disaggregation of particles which would result in increased nanoparticle-
membrane interactions.  
Sizing data for both the BSA and serum data would also prove useful in light of the 
important consequences of nanoparticle aggregation in vivo (Gosens et al. 2010). As 
discussed in Section 4.2.1, large aggregates can cause capillary blockages and induce an 
immune response (Fukumori and Ichikawa 2006; Neuberger et al. 2005), and as such 
understanding how serum and BSA concentrations affect nanoparticle aggregation is 
relevant to accurately modelling nanoparticle behaviours in physiological environments 
(Walkey and Chan 2011).  
4.3.1 Washes to Remove Membrane Bound Nanoparticles 
A number of different conditions were used in an attempt to remove membrane 
nanoparticles and allow for the study of nanoparticle internalisation through the plate reader 
assay used in this study. The ice cold Hank’s Balanced Salt Solution (HBSS) washes 
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performed by Georgieva et al. (2010) did not successfully remove all of the membrane 
bound signal upon analysis with a Nikon inverted A1R confocal microscope.  
Trypsin washes proved effective after 60 second washes, however these washes would 
cause cells to detach and were therefore not applicable for the purposes of this study. As 
shown in Section 3.5, the most effective protocol proved to be a series of 5 minute HBSS 
washes and 30 second incubations with an alternative protease, Accutase. However even 
this method did not completely remove the membrane bound signal, and in order for a 
study of nanoparticle internalisation to be performed using the plate reader study a protocol 
is needed that would effectively remove 100% of membrane bound nanoparticles.  
4.3.2 Future Work 
As the most dramatic removal of membrane bound nanoparticles was achieved by 4 rounds 
of 5 minute HBSS washes followed by 30 seconds of Accutase, future development of this 
protocol should investigate using more extensive washes to remove the last of the 
membrane associated signal. Using 5 or 6 rounds of washes for example could prove 
successful.  
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SECTION 5: CONCLUDING REMARKS 
In this study the relationship between serum and its resultant effects on surface charge and 
the binding of polystyrene nanoparticles to the plasma membrane has been investigated. 
The previously reported inhibitory effect of serum on polystyrene nanoparticle interactions 
with the plasma membrane has been shown to depend on both the concentration of serum 
and the size of the particles in question.  
Furthermore the reduction in zeta potential evidenced by the formation of a protein corona 
was shown to affect particles of all three sizes investigated equally. The data to hand 
suggests that a stable corona forms at a relatively low concentration of serum 
(approximately 1%), while the reduction in plasma membrane binding induced by the 
corona continues to increase as the concentration of serum increases. This finding warrants 
further investigation into the proteins adsorbing to the polystyrene FluoSpheres tested, and 
how the composition of the corona changes in response to changing protein abundance.  
Bovine serum albumin (BSA) in concentrations equivalent to those found in serum did not 
reproduce the effect observed in the presence of serum. However an observation of interest 
was an increase in membrane-associated signal at low concentrations of BSA, a finding 
which could be attributed to the potential disaggregation of particles in these conditions.  
Understanding how the presence of biological media affects nanoparticle interactions with 
cells and tissues is a matter of concern as exposure to nanomaterials through various routes 
increases (McCall 2011). The findings reported in this study contribute to a deeper 
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understanding of how factors like particle size, protein abundance, and surface charge 
affect nanoparticle interactions with cells.  
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